Sign In
Learn bits
Science & Tech.
Komal gupta

24/02/22 13:20 PM IST

Source: PIB

CORBEVAX

In News

CORBEVAXTM is India’s first indigenously developed receptor binding domain protein sub-unit vaccine for COVID-19.

About the Vaccine:

  • This is developed by Biological E Limited with the support of the Department of Biotechnology and Biotechnology Industry Research Assistance Council (BIRAC). 
  • It is a recombinant protein vaccine which uses the receptor binding domain of the spike protein on the viral surface. 
  • It is a double dose vaccine that is administered intramuscularly and stored at 2° C to 8° C.

More Related Current Affairs View All

20 Feb

The Maharashtra Protection of Interest of Depositors (in Financial Establishments) Act, 1999

'Investors who were defrauded in the Torres Ponzi scam may receive about Rs 40 crore over the next six months.' The Mumbai Police’s Economic Offences Wing (EOW) has begun

Read More

18 Feb

Aravali safari park project

'The Haryana government’s ambitious 3,858 hectare Aravali safari park project spread across Gurugram and Nuh — which was one of the poll promises of the ruling Bharatiy

Read More

17 Feb

President’s rule function

'Recently,  four days after Manipur Chief Minister N. Biren Singh’s resignation, the Union government announced that President’s rule has been implemented in the v

Read More

India’s First Ai-Driven Magazine Generator

Generate Your Custom Current Affairs Magazine using our AI in just 3 steps